NRSA Training Core

NRSA 培训核心

• 批准号: 10348903
• 负责人: Emma Anne Meagher
• 金额: $ 84.87万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-07-01 至 2026-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10348903
• 关键词: Appointment; Awareness; Biography; Caliber; Career Choice; Categories; Certification; Cities; Clinical; Code; Competence; Country; County; Coupled; Data Science; Development; Discipline; Doctor of Philosophy; Educational Curriculum; Educational workshop; Electronic Mail; First Name; Funding; Funding Opportunities; Grant; Health Priorities; Healthcare; Industry; Investigation; K-Series Research Career Programs; Knowledge; Last Name; Lead; Master' s Degree; Mentors; Mission; Names; National Research Service Awards; Patient Care; Peer Review; Pennsylvania; Persons; Pharmacy facility; Positioning Attribute; Principal Investigator; Province; Publications; Research; Research Personnel; Review Literature; Role; Science; Scientist; Solid; Specific qualifier value; TNFSF15 gene; Telefacsimile; Telephone; Therapeutic; Time; Training; Training Programs; Training Support; Translating; Translational Research; Translations; United States; Universities; base; biomedical informatics; career; clinical care; cohort; design; diversity and inclusion; expectation; expiration; flexibility; implementation science; improved; innovation; medical schools; next generation; pre-doctoral; programs; recruit; skills; skills training; training opportunity

Contact PD/PI: FITZGERALD, GARRET A NRSA-Training-001 (532) TL1 Abstract: NRSA Training Core The purpose of the Penn NRSA Training Core is to enhance training in clinical translational science (CTS) to expedite the translation of scientific discovery into therapy and improve the quality of patient care. The mission of our TL1 program is to (i) recruit and train a next generation of CTS investigators who are equipped with the awareness, knowledge and skills necessary to successfully translate discoveries into clinical care, and (ii) to prepare them for a range of research careers. Penn’s TL1 program is designed to attract, train and support a diverse cohort of predoctoral trainees from graduate research programs (PhD, MD/PhD, VMD/PhD) and clinical training programs (MD, VMD, DMD) as well as postdoctoral research scientists (PhD) and clinicians (MD, VMD, DMD). Appointees enter their CTS training from various educational trajectories and with diverse expectations and career aspirations; for this reason the Penn TL1 is flexible and inclusive of cross-disciplinary coursework and/or completion of a graduate-level certificate or Master’s degree. Appointment durations vary between one year for predoctoral appointees and either one or 2-3 years for postdoctoral appointees. Predoctoral trainees will complete the TL1 with a solid understanding of the discipline and core competencies for performing CTS research. Postdoctoral trainees will have demonstrated CTS research independence in the form of publication in peer-reviewed literature, appointment to a mentored career development award or other independent grant funding and an academic or industry appointment with continued substantial engagement in CTS. Coupled with a dedicated mentoring program and a robust diversity and inclusion effort, the objectives of the TL1 program are based on the following: 1. (i) Continue to provide a comprehensive curriculum in discovery-, entrepreneurial-, and regulatory science, translational therapeutics, and biomedical informatics; (ii) expand coursework to include data- and implementation science, investigational pharmacy, and health care innovation; and (iii) continue to increase the awareness of CTS training opportunities to recruit high caliber trainees. 2. (i) Continue development efforts on professional skills training, and (ii) add programs to support postdoctoral trainees at points of transition and prepare postdoctoral PhDs for diverse career paths. 3. Develop skills-based workshops and labs for all TL1 trainees that are responsive to real-time innovations in science, shifting health priorities and rapidly evolving learner needs. 4. Expand opportunities for pre- and postdoctoral trainees to immerse themselves in projects at the academic- industry interface through the creation of shared training programs so that they may partake in real-world scenarios of innovation being reduced to practice. Project Summary/Abstract Page 1246 Contact PD/PI: FITZGERALD, GARRET A NRSA-Training-001 (532) OMB Number: 4040-0010 Expiration Date: 12/31/2022 RESEARCH & RELATED Senior/Key Person Profile (Expanded) PROFILE - Project Director/Principal Investigator Prefix: First Name*: Emma Middle Name Anne Last Name*: Meagher Suffix: Position/Title*: Senior Associate Dean for Clinical Res Organization Name*: University of Pennsylvania Department: Division: Street1*: ITMAT - Perelman School of Medicine Street2: 3400 Spruce Street City*: PHILADELPHIA County: State*: PA: Pennsylvania Province: Country*: USA: UNITED STATES Zip / Postal Code*: 191040000 Phone Number*: 215-662-2174 Fax Number: E-Mail*: [e-mail] Credential, e.g., agency login: emeagher Project Role*: Other (Specify) Other Project Role Category: Project Lead Degree Type: MD Degree Year: 1987 Attach Biographical Sketch*: File Name: Attach Current & Pending Support: File Name: Page 1247 Tracking Number: GRANT13073932 Funding Opportunity Number: PAR-18-940 . Received Date: 2020-04-16T15:07:17.000-04:00

联系 PD/PI：FITZGERALD、GARRET A NRSA-Training-001 (532) TL1 摘要：NRSA 培训核心 Penn NRSA 培训核心的目的是加强临床转化科学 (CTS) 培训，以 加快将科学发现转化为治疗并提高患者护理质量。使命 我们 TL1 计划的目的是 (i) 招募和培训下一代 CTS 调查员，他们配备了 成功将发现转化为临床护理所需的意识、知识和技能，以及 (ii) 为他们的一系列研究职业做好准备。宾夕法尼亚大学的 TL1 计划旨在吸引、培训和支持 来自研究生研究项目（博士、医学博士/博士、VMD/博士）和临床的不同博士前培训生群体 培训计划（MD、VMD、DMD）以及博士后研究科学家（PhD）和临床医生（MD、VMD、 DMD）。被任命者从不同的教育轨迹和不同的期望开始 CTS 培训 和职业抱负；因此，Penn TL1 非常灵活且包含跨学科课程 和/或完成研究生水平证书或硕士学位。预约持续时间各不相同 博士前任命者为一年，博士后任命者为一年或2-3年。博士前培训生将 完成 TL1，对执行 CTS 的学科和核心能力有深入的了解 研究。博士后学员将以出版物的形式展示 CTS 研究的独立性 在同行评审的文献中，获得指导职业发展奖或其他独立资助的任命 资金和学术或行业任命，并持续大量参与 CTS。加上 专门的指导计划以及强有力的多元化和包容性努力，TL1 计划的目标是 基于以下内容： 1. (i) 继续提供发现科学、创业科学和监管科学方面的综合课程， 转化疗法和生物医学信息学； (ii) 扩大课程作业以包括数据和 实施科学、研究药学和医疗保健创新； (iii) 继续增加 了解 CTS 招募高素质学员的培训机会。 2.（i）继续开展专业技能培训工作，（ii）增加博士后支持项目 处于过渡阶段的实习生，并为博士后博士学位做好不同职业道路的准备。 3. 为所有 TL1 学员开发基于技能的研讨会和实验室，以响应实时创新 科学、不断变化的健康优先事项和快速变化的学习者需求。 4. 为博士前和博士后培训生提供更多机会，让他们沉浸在学术项目中 通过创建共享培训计划建立行业接口，以便他们可以参与现实世界 将创新付诸实践的场景。 项目摘要/摘要页 1246 联系 PD/PI：FITZGERALD、GARRET A NRSA-Training-001 (532) OMB 编号：4040-0010 到期日期：2022 年 12 月 31 日 研究及相关高级/关键人物简介（扩展） 简介 - 项目总监/首席研究员 前缀： 名字*： 艾玛 中间名 安妮 姓氏*： Meagher 后缀： 职位/头衔*：临床研究高级副院长 组织名称*：宾夕法尼亚大学 部门： 分配： Street1*：ITMAT - 佩雷尔曼医学院 街道 2：云杉街 3400 号 城市*: 费城 县： 州*：宾夕法尼亚州：宾夕法尼亚州 省： 国家*： 美国： 美国 邮政编码*：191040000 电话号码*： 215-662-2174 传真号码： 电子邮件*：[e-mail] 凭证，例如机构登录：emeagher 项目角色*： 其他（请注明） 其他项目角色类别： 项目负责人 学位类型：医学博士学位年份：1987 附上简历*： 文件名： 附上当前和待定的支持： 文件名： 第1247页 跟踪编号：GRANT13073932 资助机会编号：PAR-18-940。收到日期： 2020-04-16T15:07:17.000-04:00